Cancer Research Audrey Hepburn Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maudsley, S.
Right arrow Articles by Millar, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maudsley, S.
Right arrow Articles by Millar, R. P.
[Cancer Research 64, 7533-7544, October 15, 2004]
© 2004 American Association for Cancer Research

Regular Articles

Gonadotropin-Releasing Hormone (GnRH) Antagonists Promote Proapoptotic Signaling in Peripheral Reproductive Tumor Cells by Activating a G{alpha}i-Coupling State of the Type I GnRH Receptor

Stuart Maudsley1,2, Lindsay Davidson1, Adam J. Pawson1, Raymond Chan1, Rakel López de Maturana3 and Robert P. Millar1,4

1 Medical Research Council Human Reproductive Sciences Unit, Edinburgh, United Kingdom; 2 National Institutes of Health National Institute on Aging, Johns Hopkins Medical Center, Gerontology Research Center, Baltimore, Maryland; 3 Ardana Bioscience, Edinburgh, United Kingdom; and 4 Division of Medical Biochemistry, University of Cape Town Faculty of Health Sciences, Cape Town, South Africa

Gonadotropin-releasing hormone (GnRH) receptor agonists are extensively used in the treatment of sex hormone-dependent cancers via the desensitization of pituitary gonadotropes and consequent decrease in steroid sex hormone secretion. However, evidence now points to a direct inhibitory effect of GnRH analogs on cancer cells. These effects appear to be mediated via the G{alpha}i-type G protein, in contrast to the predominant G{alpha}q coupling in gonadotropes. Unlike G{alpha}q coupling, G{alpha}i coupling of the GnRH receptor can be activated by both agonists and antagonists. This unusual pharmacology suggested that the receptor involved in the cancer cells may not be the classical gonadotrope type I GnRH receptor. However, we have previously shown that a functional type II GnRH receptor is not present in man. In the present study, we show that GnRH agonists and selective GnRH antagonists exert potent antiproliferative effects on JEG-3 choriocarcinoma, benign prostate hyperplasia (BPH-1), and HEK293 cells stably expressing the type I GnRH receptor. This antiproliferative action occurs through a G{alpha}i-mediated activation of stress-activated protein kinase pathways, resulting in caspase activation and transmembrane transfer of phosphatidlyserine to the outer membrane envelope. Structurally related antagonistic GnRH analogs displayed divergent antiproliferative efficacies but demonstrated equal efficacies in inhibiting GnRH-induced G{alpha}q-based signaling. Therefore the ability of GnRH receptor antagonists to exert an antiproliferative effect on reproductive tumors may be dependent on ligand-selective activation of the G{alpha}i-coupled form of the type I GnRH receptor.




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
L. Wang, B. Martin, R. Brenneman, L. M. Luttrell, and S. Maudsley
Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders
J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 340 - 348.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Fister, A. R. Gunthert, B. Aicher, K. W. Paulini, G. Emons, and C. Grundker
GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax
Cancer Res., August 15, 2009; 69(16): 6473 - 6481.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H.-M. Wu, J.-C. Cheng, H.-S. Wang, H.-Y. Huang, C. D. MacCalman, and P. C.K. Leung
Gonadotropin-Releasing Hormone Type II Induces Apoptosis of Human Endometrial Cancer Cells by Activating GADD45{alpha}
Cancer Res., May 15, 2009; 69(10): 4202 - 4208.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D.-K. Kim, J. S. Yang, K. Maiti, J.-I. Hwang, K. Kim, D. Seen, Y. Ahn, C. Lee, B.-C. Kang, H. B. Kwon, et al.
A Gonadotropin-Releasing Hormone-II Antagonist Induces Autophagy of Prostate Cancer Cells
Cancer Res., February 1, 2009; 69(3): 923 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Integr. Comp. Biol.Home page
J. S. Schneider and E. F. Rissman
Gonadotropin-releasing hormone II: a multi-purpose neuropeptide
Integr. Comp. Biol., November 1, 2008; 48(5): 588 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. D. White, M. Coetsee, K. Morgan, C. A. Flanagan, R. P. Millar, and Z.-L. Lu
A Crucial Role for G{alpha}q/11, But Not G{alpha}i/o or G{alpha}s, in Gonadotropin-Releasing Hormone Receptor-Mediated Cell Growth Inhibition
Mol. Endocrinol., November 1, 2008; 22(11): 2520 - 2530.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Morgan, A. J. Stewart, N. Miller, P. Mullen, M. Muir, M. Dodds, F. Medda, D. Harrison, S. Langdon, and R. P. Millar
Gonadotropin-Releasing Hormone Receptor Levels and Cell Context Affect Tumor Cell Responses to Agonist In vitro and In vivo
Cancer Res., August 1, 2008; 68(15): 6331 - 6340.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. Lopez de Maturana, A. J. Pawson, Z.-L. Lu, L. Davidson, S. Maudsley, K. Morgan, S. P. Langdon, and R. P. Millar
Gonadotropin-Releasing Hormone Analog Structural Determinants of Selectivity for Inhibition of Cell Growth: Support for the Concept of Ligand-Induced Selective Signaling
Mol. Endocrinol., July 1, 2008; 22(7): 1711 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. J. Pawson, E. Faccenda, S. Maudsley, Z.-L. Lu, Z. Naor, and R. P. Millar
Mammalian Type I Gonadotropin-Releasing Hormone Receptors Undergo Slow, Constitutive, Agonist-Independent Internalization
Endocrinology, March 1, 2008; 149(3): 1415 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
A. R Finch, K. R Sedgley, C. J Caunt, and C. A McArdle
Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines
J. Endocrinol., February 1, 2008; 196(2): 353 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. J. Stewart, R. Sellar, D. J. Wilson, R. P. Millar, and Z.-L. Lu
Identification of a Novel Ligand Binding Residue Arg38(1.35) in the Human Gonadotropin-Releasing Hormone Receptor
Mol. Pharmacol., January 1, 2008; 73(1): 75 - 81.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Gardner, S. Maudsley, R. P. Millar, and A. J. Pawson
Nuclear Stabilization of {beta}-Catenin and Inactivation of Glycogen Synthase Kinase-3{beta} by Gonadotropin-Releasing Hormone: Targeting Wnt Signaling in the Pituitary Gonadotrope
Mol. Endocrinol., December 1, 2007; 21(12): 3028 - 3038.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Yanamadala, H. Negoro, L. Gunaratnam, T. Kong, and B. M. Denker
G{alpha}12 Stimulates Apoptosis in Epithelial Cells through JNK1-mediated Bcl-2 Degradation and Up-regulation of I{kappa}B{alpha}
J. Biol. Chem., August 17, 2007; 282(33): 24352 - 24363.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
P. C.K. Leung and J.-H. Choi
Endocrine signaling in ovarian surface epithelium and cancer
Hum. Reprod. Update, March 1, 2007; 13(2): 143 - 162.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. S. Struthers, Q. Xie, S. K. Sullivan, G. J. Reinhart, T. A. Kohout, Y.-F. Zhu, C. Chen, X.-J. Liu, N. Ling, W. Yang, et al.
Pharmacological Characterization of a Novel Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor, NBI-42902
Endocrinology, February 1, 2007; 148(2): 857 - 867.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
B.C. Tarlatzis, B.C. Fauser, E.M. Kolibianakis, K. Diedrich, P. Devroey, and , On Behalf of the Brussels GnRH Antagonist Consen
GnRH antagonists in ovarian stimulation for IVF
Hum. Reprod. Update, July 1, 2006; 12(4): 333 - 340.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. K. Barnett, T. M. Bunnell, R. P. Millar, and D. H. Abbott
Gonadotropin-Releasing Hormone II Stimulates Female Sexual Behavior in Marmoset Monkeys
Endocrinology, January 1, 2006; 147(1): 615 - 623.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z.-L. Lu, R. Gallagher, R. Sellar, M. Coetsee, and R. P. Millar
Mutations Remote from the Human Gonadotropin-releasing Hormone (GnRH) Receptor-binding Sites Specifically Increase Binding Affinity for GnRH II but Not GnRH I: EVIDENCE FOR LIGAND-SELECTIVE, RECEPTOR-ACTIVE CONFORMATIONS
J. Biol. Chem., August 19, 2005; 280(33): 29796 - 29803.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Maudsley, B. Martin, and L. M. Luttrell
The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 485 - 494.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. J. Pawson, S. Maudsley, K. Morgan, L. Davidson, Z. Naor, and R. P. Millar
Inhibition of Human Type I Gonadotropin-Releasing Hormone Receptor (GnRHR) Function by Expression of a Human Type II GnRHR Gene Fragment
Endocrinology, June 1, 2005; 146(6): 2639 - 2649.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.